论文部分内容阅读
目的:探索培菲康在治疗幽门螺杆菌感染慢性胃炎中的临床作用。方法:选取我院的50例慢性胃炎患者,分为观察组和对照组,每组各有25例患者,对照组采用常规治疗,观察组采用培菲康治疗,对比两组患者的总有效率、幽门螺杆菌根除率、不良反应发生率。结果:观察组患者的总有效率、幽门螺杆菌根除率、不良反应发生率显著优于对照组(P<0.05)。结论:培菲康在治疗幽门螺杆菌感染慢性胃炎中效果确切。
Objective: To explore the clinical effect of Pefikan in the treatment of Helicobacter pylori infection in chronic gastritis. Methods: Fifty patients with chronic gastritis in our hospital were selected and divided into observation group and control group, with 25 patients in each group. The control group was treated routinely. The observation group was treated with Pefikan. The total effective rate , Helicobacter pylori eradication rate, the incidence of adverse reactions. Results: The total effective rate, the eradication rate of Helicobacter pylori and the incidence of adverse reactions in the observation group were significantly better than those in the control group (P <0.05). Conclusion: Peifen Kang in the treatment of Helicobacter pylori infection with chronic gastritis in the exact effect.